Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Tiotropium Easyhaler vs Spiriva HandiHaler
NCT03400241Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- Feb 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Orion Corporation. Primary endpoints: Peak Plasma Concentration, Area Under the Concentration-Time Curve 0-72h and 1 more. Started Feb 2018; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03400241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400241.